Dendritic Cells Therapy
Your immune system is naturally designed to fight harmful invaders, including cancer cells. However, cancer can sometimes evade detection. Dendritic Cell Therapy boosts your immune system by training it to recognize and attack cancer cells.
At Swissmed Health, we collect your dendritic cells, enhance their ability to detect cancer, and reintroduce them into your body to initiate a targeted immune response. This therapy is customized to your specific type of cancer, offering a safer and more personalized treatment option compared to traditional therapies.
Benefits of Dendritic Cell Therapy:
Targeted Cancer Attack: Trains your immune system to precisely identify and destroy cancer cells.
Personalized Treatment: Tailored to your unique immune and cancer profile.
Minimized Side Effects: Avoids the systemic toxicity of chemotherapy and radiation.
Immune System Boost: Strengthens your overall immune function.
Complementary Approach: Works alongside traditional treatments for enhanced effectiveness.
Medical Article Summary
Dendritic Cell Therapy is an advanced immunotherapy that leverages dendritic cells, which act as the “sentinels” of the immune system. These cells process antigens from cancer cells and present them to T-cells, triggering a precise immune attack against the tumor.
How Dendritic Cell Therapy Works
Cell Harvesting: Dendritic cells are collected from the patient’s blood.
Cancer Antigen Loading: These cells are exposed to antigens from the patient’s tumor, training them to recognize cancer-specific markers.
Reintroduction: The activated dendritic cells are injected back into the patient, where they stimulate T-cells to attack the cancer.
Immune Response Amplification: The therapy enhances the immune system’s ability to detect and destroy cancer cells, reducing tumor growth.
Applications of Dendritic Cell Therapy
Solid Tumors: Effective for cancers like breast, prostate, and lung cancer.
Hematological Cancers: Targets conditions such as leukemia and lymphoma.
Relapsed or Resistant Cancers: Offers hope for patients with limited options.
Clinical Evidence
A 2022 study in Cancer Immunology Research demonstrated that dendritic cell-based vaccines significantly improved survival rates in patients with advanced melanoma. Another study in Nature Reviews Cancer highlighted dendritic cell therapy’s ability to enhance the efficacy of other immunotherapies, such as checkpoint inhibitors.
Medical Article Link
Link: Dendritic Cell-Based Cancer Vaccines
Summary: A 2023 review in Frontiers in Immunology confirmed the safety and effectiveness of dendritic cell therapy in activating anti-tumor immune responses. The study emphasized the therapy’s potential to improve outcomes in resistant and advanced-stage cancers when used in combination with other treatments.